Mastodon

Elentra Nutrition® Potassium + Magnesium aspartate (Capsules) Instructions for Use

Marketing Authorization Holder

Grotex, LLC (Russia)

Dosage Form

Bottle OTC Icon Elentra Nutrition Potassium + Magnesium aspartate Capsules 100 mg+50 mg: 120 pcs.

Dosage Form, Packaging, and Product Composition

Capsules with a mass of 955 mg.

1 dose (6 caps.) Daily Intake Levels % of RSP*
Potassium (in the form of magnesium-potassium aspartate) 600 mg 3500 mg* 17%
Magnesium (in the form of magnesium-potassium aspartate) 300 mg 400 mg*-800 mg** 75%

* RSP – Recommended Daily Intake level according to TR TS 022/2011 standards, Appendix 2;
** Upper permissible daily intake level according to the “Unified Sanitary-Epidemiological and Hygienic Requirements for Goods Subject to Sanitary-Epidemiological Surveillance (Control)”, Appendix 5.

Excipients: Hydroxypropyl methylcellulose capsule (E464, carrier), silicon dioxide (E551, anticaking agent), stearic acid (E570, carrier).

120 pcs. – polymer bottles.

Therapeutic Category

Dietary supplement – an additional source of potassium and magnesium

Properties

Dietary supplement. Magnesium and Potassium are intracellular elements.

Magnesium activates enzymes that regulate carbohydrate metabolism, stimulates protein formation, reduces excitation in nerve cells, and relaxes the heart muscle.

Potassium is necessary for normal muscle contractions and maintaining blood pressure. The role of potassium in maintaining acid-base balance is important. Signs of potassium deficiency in the body may include heart disease and nervous system disorders.

Maintaining the balance of potassium and magnesium contributes to: preserving cardiovascular system health; conduction of nerve impulses; maintaining acid-base balance.

Scope of Application

As a dietary supplement – an additional source of potassium and magnesium.

ICD codes

ICD-10 code Indication
E61.2 Magnesium deficiency
E63.8 Other specified types of nutritional deficiency
ICD-11 code Indication
5B7Z Malnutrition, unspecified
5C64.41 Magnesium deficiency
8D40.0 Encephalopathy due to nutritional deficiency
8D40.2 Myopathy due to nutritional deficiency

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Orally, preferably after meals, 3 times/day.

The duration of administration is 1 month. If necessary, the course can be repeated throughout the year.

Side Effects

Possible hypersensitivity reactions to the product components.

Contraindications

Individual intolerance to the dietary supplement components; pregnancy, breastfeeding period.

Use During Pregnancy and Lactation

Contraindicated for use during pregnancy and breastfeeding.

Special Instructions

A dietary supplement to food, not a medicinal product.

It is recommended to consult a doctor before use.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS